Deng Han, Qi Xingshun, Peng Ying, Li Jing, Li Hongyu, Zhang Yongguo, Liu Xu, Sun Xiaolin, Guo Xiaozhong
Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang, Liaoning, China (mainland).
Med Sci Monit. 2015 Dec 20;21:3961-77. doi: 10.12659/msm.895005.
BACKGROUND Aspartate aminotransferase-to-platelet ratio index (APRI), aspartate aminotransferase-to-alanine aminotransferase ratio (AAR), FIB-4, fibrosis index (FI), and King scores might be alternatives to the use of upper gastrointestinal endoscopy for the diagnosis of esophageal varices (EVs) in liver cirrhosis. This study aimed to evaluate their diagnostic accuracy in predicting the presence and severity of EVs in liver cirrhosis. MATERIAL AND METHODS All patients who were consecutively admitted to our hospital and underwent upper gastrointestinal endoscopy between January 2012 and June 2014 were eligible for this retrospective study. Areas under curve (AUCs) were calculated. Subgroup analyses were performed according to the history of upper gastrointestinal bleeding (UGIB) and splenectomy. RESULTS A total of 650 patients with liver cirrhosis were included, and 81.4% of them had moderate-severe EVs. In the overall analysis, the AUCs of these non-invasive scores for predicting moderate-severe EVs and presence of any EVs were 0.506-0.6 and 0.539-0.612, respectively. In the subgroup analysis of patients without UGIB, their AUCs for predicting moderate-severe varices and presence of any EVs were 0.601-0.664 and 0.596-0.662, respectively. In the subgroup analysis of patients without UGIB or splenectomy, their AUCs for predicting moderate-severe varices and presence of any EVs were 0.627-0.69 and 0.607-0.692, respectively. CONCLUSIONS APRI, AAR, FIB-4, FI, and King scores had modest diagnostic accuracy of EVs in liver cirrhosis. They might not be able to replace the utility of upper gastrointestinal endoscopy for the diagnosis of EVs in liver cirrhosis.
天冬氨酸转氨酶与血小板比值指数(APRI)、天冬氨酸转氨酶与丙氨酸转氨酶比值(AAR)、FIB-4、纤维化指数(FI)和King评分可能是用于诊断肝硬化食管静脉曲张(EVs)的替代上消化道内镜检查的方法。本研究旨在评估它们在预测肝硬化患者EVs的存在及严重程度方面的诊断准确性。
本回顾性研究纳入了2012年1月至2014年6月期间连续入住我院并接受上消化道内镜检查的所有患者。计算曲线下面积(AUCs)。根据上消化道出血(UGIB)病史和脾切除术进行亚组分析。
共纳入650例肝硬化患者,其中81.4%有中重度EVs。在总体分析中,这些无创评分预测中重度EVs和任何EVs存在的AUCs分别为0.506 - 0.6和0.539 - 0.612。在无UGIB患者的亚组分析中,其预测中重度静脉曲张和任何EVs存在的AUCs分别为0.601 - 0.664和0.596 - 0.662。在无UGIB或脾切除术患者的亚组分析中,其预测中重度静脉曲张和任何EVs存在的AUCs分别为0.627 - 0.69和0.607 - 0.692。
APRI、AAR、FIB-4、FI和King评分在肝硬化EVs诊断中的准确性一般。它们可能无法替代上消化道内镜检查在肝硬化EVs诊断中的作用。